Schonfeld Strategic Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-39,268
| Closed | -$376K | – | 2548 |
|
|
2022
Q3 | $376K | Buy |
39,268
+7,614
| +24% | +$72.9K | ﹤0.01% | 1908 |
|
|
2022
Q2 | $229K | Buy |
+31,654
| New | +$229K | ﹤0.01% | 1740 |
|
|
2022
Q1 | – | Sell |
-23,000
| Closed | -$367K | – | 2409 |
|
|
2021
Q4 | $367K | Buy |
+23,000
| New | +$367K | ﹤0.01% | 1359 |
|
|
2021
Q2 | – | Sell |
-19,103
| Closed | -$279K | – | 1941 |
|
|
2021
Q1 | $279K | Buy |
+19,103
| New | +$279K | ﹤0.01% | 1323 |
|
|
2020
Q2 | – | Sell |
-24,952
| Closed | -$405K | – | 1233 |
|
|
2020
Q1 | $405K | Sell |
24,952
-35,796
| -59% | -$581K | 0.03% | 653 |
|
|
2019
Q4 | $1.09M | Buy |
+60,748
| New | +$1.09M | 0.03% | 486 |
|
|
2019
Q3 | – | Sell |
-79,600
| Closed | -$1.76M | – | 1023 |
|
|
2019
Q2 | $1.76M | Sell |
79,600
-177,100
| -69% | -$3.91M | 0.06% | 313 |
|
|
2019
Q1 | $3.5M | Buy |
+256,700
| New | +$3.5M | 0.12% | 226 |
|